In the latest effort by the Trump administration to reduce costs and increase access to anti-obesity medications like Ozempic ...
The Centers for Medicare and Medicaid extended the Bridge program, which makes GLP-1s for obesity available for $50, through the end of 2027.
New funding through FHWA aims to help states and local agencies advance bridge rehabilitation while expanding access for ...
Fact checked by Jennifer Klump Key Takeaways The Medicare GLP-1 Bridge program will cover weight loss drugs for a $50 monthly ...
Learn who qualifies for Medicare’s GLP-1 Bridge, when $50 Wegovy and Zepbound access begins, and key rules beneficiaries need ...